Nucleo

Nucleo

Automated cancer diagnostics

In the rapidly evolving landscape of Artificial Intelligence, the development of 'world models' represents a critical frontier, with leading research labs intensely focused on applications in robotics, generalist AI agents, and autonomous vehicles. Nucleo Research Inc. stands apart as the pioneering entity applying this revolutionary AI paradigm specifically to oncology. We are the first to harness the power of world models to create advanced simulations and predictive analytics tailored for cancer research and treatment, aiming to unlock unprecedented insights and accelerate breakthroughs in the fight against disease.

Categories:

Pitch NYC

Launch Team / Built with

LP
AI

Launch Date:

May 9, 2026